Effect of potassium channel openers in acute and chronic models of glaucoma

Shital S Panchal1, Anita A Mehta2, Devdas D Santani3

  • 1Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad 382481, Gujarat, India.

Abstract

Insights

Nicorandil and pinacidil effectively lowered intraocular pressure (IOP) in glaucoma models. Their oculohypotensive effect, likely mediated by potassium channels, enhances aqueous humor outflow.

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Glaucoma is a leading cause of irreversible blindness, characterized by elevated intraocular pressure (IOP).
  • Understanding the mechanisms and therapeutic agents for IOP reduction is crucial for glaucoma management.

Purpose of the Study:

  • To investigate the effects of nicorandil and pinacidil on intraocular pressure (IOP) in experimental acute and chronic glaucoma models.
  • To elucidate the mechanism of action underlying the IOP-modulating effects of these agents.

Main Methods:

  • Topical administration of nicorandil (1%), pinacidil (1%), and pilocarpine (1%) in New Zealand white rabbits.
  • Induction of acute glaucoma using dextrose (5%) and chronic glaucoma using α-chymotrypsin.
  • Measurement of IOP at regular intervals using a tonometer.
  • Investigating drug mechanisms using glibenclamide, pilocarpine, and indomethacin.

Main Results:

  • Nicorandil and pinacidil significantly reduced IOP in acute glaucoma models.
  • In chronic glaucoma, these drugs initially increased IOP (15-30 min) before causing a sustained reduction.
  • Glibenclamide pretreatment blocked the IOP-lowering effect, suggesting involvement of ATP-sensitive potassium channels.

Conclusions:

  • The oculohypotensive effect of nicorandil and pinacidil is likely mediated by enhancing aqueous humor outflow.
  • Potassium channels appear to play a significant role in the mechanism of action for these drugs in reducing IOP.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
744
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.4K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.9K